LAVA Medtech Acquisition Corp. Unit
LVACU
LVACU was delisted on the 19th of April, 2023.
11 hedge funds and large institutions have $11.1M invested in LAVA Medtech Acquisition Corp. Unit in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.
6% less capital invested
Capital invested by funds: $11.7M → $11.1M (-$676K)
21% less funds holding
Funds holding: 14 → 11 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
-$403K |
| 2 |
Calamos Advisors
Naperville,
Illinois
|
-$251K |
| 3 |
CS
Clear Street
New York
|
-$58K |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$493 |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$10 |
LVACU Hedge Fund Activity: Q3 2022 in Review
11 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Unit (LVACU) for Q3 2022, worth a combined $11.1M — down 5.8% from $11.7M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of LVACU and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Schonfeld Strategic Advisors, cutting an estimated $403K.
- 11 institutional investors held LAVA Medtech Acquisition Corp. Unit (LVACU) as of Q3 2022, down from 14 in Q2 2022.
- Funds reported $11.1M of LAVA Medtech Acquisition Corp. Unit stock for Q3 2022, down 5.8% quarter-over-quarter.
- 0 funds opened new LAVA Medtech Acquisition Corp. Unit positions in Q3 2022 and 3 closed out, a net change of -3 holders.
- The largest LAVA Medtech Acquisition Corp. Unit seller in Q3 2022 was Schonfeld Strategic Advisors, an estimated $403K sold.
Based on aggregated 13F filings for Q3 2022.